Advertisement
Advertisement
U.S. markets open in 7 hours 50 minutes
Advertisement
Advertisement
Advertisement
Advertisement

BioVie Inc. (BIVI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.4700-0.1900 (-5.19%)
At close: 04:00PM EST
3.5300 +0.06 (+1.73%)
After hours: 07:49PM EST
Advertisement
Sign in to post a message.
  • D
    David
    Several emails out to Investor Relations...today..last month..last year. 2 Sources. If we don't hear from someone shortly I suppose we can be concerned. Not an optionable position..so hard to hedge..
    That being said..again..we are a couple of months away from trial data on 3 fronts..with a low barrier.
    This ..after 30 years in this business..Looks to me like like the opportunity I believe it is..
    As states prior...
    Bullish
  • D
    David
    Down 90.11% in 12 months...with 3 huge catalysts in the next 3 months....How can this happen? Look at the Chief Med Offcr who just came aboard several months ago...Its a testament as to the irrational movement's in the market...This company has multiple products..multiple applications..multiple potential revenue streams in the multi billions....I'm going down with the ship...if I have to.....
    Bullish
  • D
    David
    I have a number of emails out to 2 shareholder representatives...several times...over several months...
    Not a single response. .Dr Palumbo....where are you? Can you provide an update????
    Where are the insider purchases???
    Where is Management? Where are the TP updates?????
    So much good data coming out in several months!!!!!
    Bullish
  • D
    DAVE
    Thinking to jump to the next best stock in the market… Nano Dimensions…. It’s a no brainer.
  • D
    David
    3 months or less to 3 data points! All enormous readouts..and 3 applications each worth several billion.
    Forget about TP! Look at the Board ..and the addition of Dr Palumbo....who hasn't made inside purchases at all..But I am going to kick his A.ss! Step up Doc! You know what we have!!!!
    Bullish
  • D
    DAVE
    This is just market manipulation… no need to panic guys..
  • C
    Chari
    Why is this sliding ? 3.33!
  • K
    KaTet
    In case you missed it:
    RENO, Nev., Dec. 09, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that the Company is partnering with the American Liver Foundation (ALF) in an educational campaign about chronic liver cirrhosis and its complications and to raise awareness among potential patients and healthcare providers about the Company’s Phase 2b Study of BIV201 (continuous infusion terlipressin). The trial— A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients with Cirrhosis and Refractory Ascites —is being conducted at ten prestigious research centers in the U.S.
  • D
    David
    Don't give up on this! The next 5 months are going to be mind blowing.. regardless of TP...Take a look at the Board...its almost unreal...
    Bullish
  • D
    David
    Now that tax loss selling is over..and 2022 being catalyst rich for Biovie...This will move up quickly....Very very quickly.....
    Bullish
  • D
    David
    Now the Parkinsons trial is underway! So many catalysts in 2022! This will make the SAVA run look small....BIVI..Biggest name in 2022
    Bullish
  • K
    KaTet
    RENO, Nev., Dec. 01, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, entered into a debt facility with Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P. (Collectively “the Avenue Venture Funds”) providing up to $25 million with the initial $15 million funded at the close on November 30, 2021.
  • P
    Petr
    This is good news for longevity. This is all good especially since it is NOT dilution. Same effect to have stability, but doesn't hurt us! Good and LONG term, folks! This will make you alot of money! IMHO!
  • D
    David
    Why aren't we asking where the insider buys are from the CEO and new CMO??? shouldn't we be asking that question as this makes all time lows daily with multiple phase 2 and phase 3 studies inbound?????????
    Bullish
  • K
    KaTet
    Price target reduced to $28???
    I think I’d soil myself if quadrupled. GL
  • K
    KaTet
    Now I regret muting @David. He was bipolar yet entertaining. This forum is too quiet. GL
  • D
    David
    If you were able to score any of this company in the 4s ...2022 will be a life changing event for you
    Bullish
  • D
    David
    Wow..this will be the ultimate gift ..and I mean 2/3 months away...Wait until the early release of the ascites data...and I mean really early...Going to be extraordinary...and ..well ..your about to witness an amazing move up...
    Bullish
  • D
    David
    We all understand this is a TP company...but this company has much more from high level Mgmt to inroads to the FDA..even a smbg like TP..can hit a homerun...
    He has very little involvent in this..as the higher powers have advised...This will be the Biotech story of 2022...Trust me....I know
    Bullish
  • J
    Joris
    How does this not get attention. I’ve only been here for a month.

    But volume seems extremely low. Institutions only own 1.5%

    But the gap is beautiful. I’m bullish. Just see very little communication

    Would have loved to here a response after the webcast as well
    Bullish
Advertisement
Advertisement